Cabaletta Bio

NEWS

Washington DC, USA at the Tidal Basin during spring season at night.

Cell Therapy

CAR T for Lupus Takes Center Stage at ACR 2024

Investigational CAR T therapies stole the spotlight at the American College of Rheumatology Convergence as data presented by Bristol Myers Squibb, Kyverna Therapeutics and more highlighted their potential to effectively treat lupus.

November 19, 2024

4 min read

Kate Goodwin

IN THE PRESS

Press Releases

Cabaletta Bio to Participate in Upcoming Investor Conferences in December

November 26, 2024

1 min read

Press Releases

Cabaletta Bio Presents Positive Clinical Safety and Efficacy Data on CABA-201 at ACR Convergence 2024

November 18, 2024

16 min read

Press Releases

Cabaletta Bio Reports Third Quarter 2024 Financial Results and Provides Business Update

November 15, 2024

15 min read

Press Releases

Cabaletta Bio to Participate in Guggenheim’s Inaugural Healthcare Innovation Conference

November 7, 2024

1 min read

Press Releases

Cabaletta Bio to Present New and Updated Clinical Data on CABA-201 in Oral and Poster Presentations at ACR Convergence 2024

September 26, 2024

3 min read

Press Releases

Cabaletta Bio to Participate in Upcoming Investor Conferences in September

August 28, 2024

2 min read

Business

Cabaletta Bio Reports Second Quarter 2024 Financial Results and Provides Business Update

August 8, 2024

16 min read

Pharm Country

Cabaletta Bio to Participate in the 2024 Jefferies Global Healthcare Conference

May 29, 2024

1 min read

Business

Cabaletta Bio Reports First Quarter 2024 Financial Results and Provides Business Update

May 15, 2024

14 min read

Pharm Country

Cabaletta Bio to Participate in the H.C. Wainwright 2nd Annual BioConnect Investor Conference at NASDAQ

May 13, 2024

1 min read

JOBS